Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIM.L Regulatory News (SIM)

  • There is currently no data for SIM

Exercise of Options

11 Nov 2014 08:00

RNS Number : 6548W
SimiGon Limited
11 November 2014
 



 

11 November 2014

SimiGon Ltd

("SimiGon" or the "Company")

 

Exercise of Options

 

The Company announces that, further to the exercise of options by Mr. Ami Vizer (director and chief executive officer of the Company) and a former employee, application has been made for 577,555 new ordinary shares of 0.01 NIS each in the Company ("Ordinary Shares") to be admitted to trading on AIM ("Admission") including 527,554 Ordinary Shares to Mr. Ami Vizer.

 

Pursuant to the issue of the new Ordinary Shares, Mr. Ami Vizer has a beneficial interest in 10,464,184 Ordinary Shares, representing 20.9 per cent. of the total issued share capital of the Company.

 

The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares and Admission is expected to become effective on 14 November 2014. Following this issue of new Ordinary Shares, the Company has 50,079,690 Ordinary Shares in issue and holds none in treasury. Accordingly, the total number of voting rights in the Company is 50,079,690.

 

Enquiries:

 

SimiGon Ltd

Ami Vizer, Chief Executive Officer

+1 (407) 737 7722

Efi Manea, Chief Financial Officer

 

 

 

finnCap (NOMAD & Broker)

 

Stuart Andrews / Henrik Persson (corporate finance)

+44 (0) 20 7220 0500

 

 

Luther Pendragon (Media & Investor Relations)

 

Harry Chathli, Alexis Gore, Oliver Hibberd

 +44 (0) 207 618 9100

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISLLFFTLALILIS
Date   Source Headline
2nd Aug 20193:36 pmRNSHolding(s) in Company
1st Aug 20197:00 amRNSDirectorate Changes
25th Jul 20197:00 amRNSContract Win
18th Jul 20197:00 amRNSContract Win
28th Jun 20197:00 amRNSPosting of Annual Report and Accounts
29th Apr 20197:00 amRNSSimigon kick off reseach programme with the IAF
29th Apr 20197:00 amRNSFinal Results
24th Apr 20197:00 amRNSUSAF logistics support contract extension
18th Apr 20197:00 amRNSSimigon signs BPA with the US DoD
14th Mar 20197:00 amRNSExercise of Options
14th Feb 20197:00 amRNSContract Win
14th Feb 20197:00 amRNSTrading Update
19th Dec 20187:00 amRNSContract Win
7th Dec 20185:15 pmRNSResult of AGM
2nd Nov 201812:30 pmRNSNotice of AGM
15th Oct 20187:00 amRNSFurther Contract
12th Oct 20186:00 pmRNSTransaction in Own Shares-Replacement
10th Oct 20186:21 pmRNSTransaction in Own Shares
8th Oct 20187:00 amRNSContract Win
26th Sep 20187:00 amRNSContract Win
24th Sep 20187:00 amRNSHalf-year Report
7th Sep 20184:25 pmRNSTransaction in Own Shares
17th Aug 20181:40 pmRNSTransaction in Own Shares
26th Jun 20182:26 pmRNSPosting of Annual Report and Accounts
21st Jun 20188:00 amRNSFurther Contract
6th Jun 20187:00 amRNSTransaction in Own Shares
8th May 20187:00 amRNSUSAF technician training contract
23rd Apr 20187:00 amRNSFinal Results
17th Apr 20187:00 amRNSAppointment to the Board
5th Mar 20187:00 amRNSTransaction in Own Shares
19th Feb 20187:00 amRNSContract win
7th Feb 20187:00 amRNSSimiGon awarded additional USAF support contract
16th Jan 20187:00 amRNSTrading Update
13th Dec 20177:00 amRNSDirectorate Change
1st Dec 20177:00 amRNSShare buyback programme
17th Nov 20177:00 amRNSUpdate on Strategic Contract
25th Sep 20177:00 amRNSInterim Results
8th Sep 20172:48 pmRNSResult of AGM
4th Sep 20177:00 amRNSSimiGon secures FAA contract for UAS simulation
23rd Aug 20177:00 amRNSNotice of Results
4th Aug 201711:35 amRNSNotice of AGM
2nd Aug 20172:35 pmRNSHolding(s) in Company
28th Jul 20177:00 amRNSTrading Update
5th Jul 20177:00 amRNSCompletion of milestones for US$6.7m contract
14th Jun 20177:00 amRNSPosting of Annual Report and Accounts
11th Apr 20177:00 amRNSFinal Results
16th Feb 20177:00 amRNSTrading Statement
29th Dec 20163:12 pmRNSResult of AGM
24th Nov 20162:18 pmRNSNotice of AGM
5th Oct 20167:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.